Langerhans Cell Histiocytosis (LCH) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis
Condition: Langerhans Cell HistiocytosisIntervention: Drug: ClofarabineSponsors: Dana-Farber Cancer Institute; Sanofi; St. Baldrick's Foundation; Cookies for kids cancer foundationNot yet recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2015 Category: Research Source Type: clinical trials
Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis
Condition: Langerhans Cell HistiocytosisIntervention: Drug: methotrexateSponsor: Peking Union Medical College HospitalRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2015 Category: Research Source Type: clinical trials
Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis of LungIntervention: Drug: CladribineSponsor: Assistance Publique - Hôpitaux de ParisRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2011 Category: Research Source Type: clinical trials
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Condition: Langerhans Cell HistiocytosisIntervention: Drug: GSK2110183Sponsors: Accenture; AccentureActive, not recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2011 Category: Research Source Type: clinical trials
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Condition: Langerhans Cell HistiocytosisIntervention: Drug: GSK2110183Sponsors: Octagon Research Solutions, Inc.; Octagon Research Solutions, Inc.Active, not recruiting - verified March 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2011 Category: Research Source Type: clinical trials
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Condition: Langerhans Cell HistiocytosisIntervention: Drug: GSK2110183Sponsors: Accenture; AccentureActive, not recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2011 Category: Research Source Type: clinical trials
